Life-Saving Intel: Amanda's Breast Cancer Surgeon Dr. Lucy De La Cruz

Key Takeaways

Self-advocacy and specific information are critical for breast cancer early detection and treatment decisions.
Breast density significantly impacts mammogram effectiveness, often requiring additional screenings like MRIs.
Patients have agency in choosing surgical paths, including oncoplasty, nipple preservation, and reconstruction options.
Newer surgical techniques aim to minimize trauma, restore sensation, and improve long-term quality of life.
Distinguishing between local and systemic disease treatments is crucial for preventing metastasis and ensuring survival.

Amanda Doyle emphasized the importance of 'un-gatekeeping' practical health information for self-advocacy, stating awareness without a plan leads to anxiety.
Listeners credited Amanda's transparency regarding her breast cancer experience with motivating them to seek screenings that led to their own early diagnoses.
Early detection makes breast cancer treatable, but standard screenings may not always be sufficient, prompting individuals to seek additional information.
One listener, Anna, pursued an MRI after a clear mammogram, leading to an early-stage breast cancer diagnosis 10 minutes into the episode.

Breast density is categorized from A to D; categories C (heterogeneously dense) and D (extremely dense) require additional screenings beyond mammograms.
Category D breasts, affecting 1 in 10 individuals, cause mammograms to miss 50-60% of cancers due to entirely white tissue obscuring masses.
Individuals with Category D breasts face a four to six times higher cancer risk and require MRIs for effective detection.
Patients often need to self-advocate for MRI approval by providing family history or citing their breast density, with 'mini MRI' options also available.

Dr. Lucy M. De La Cruz is a breast surgical oncologist and Chief of Breast Surgery at MedStar Georgetown University Hospital, specializing in nipple-sparing mastectomies.
She is known for her focus on structural preservation and highly specialized single-stage implant reconstruction, departing from older multi-stage methods.
Dr. De La Cruz's philosophy strongly emphasizes patient agency and choice in treatment decisions, aiming to minimize physical and emotional trauma.
A listener, Lori Mihalich-Levin, specifically sought Dr. De La Cruz for her surgery after learning from the podcast about advanced breast cancer care.

Dr. De La Cruz advocates for patient agency in breast cancer treatment decisions, highlighting that choices should stem from the patient's informed preference.
Oncoplasty, a surgical technique combining cancer removal with immediate reconstruction, is widely researched and practiced in Europe and America.
Patients may not always be fully aware of alternative procedures, leading to questions about the concept of true informed consent.
Key surgical decision points include choosing between mastectomy versus lumpectomy, immediate versus delayed reconstruction, and techniques like nipple-sparing or nerve grafting.

The initial decision in breast cancer treatment is between mastectomy, which removes all breast tissue, and lumpectomy, which removes only the cancerous lump.
This choice is influenced by factors like breast size, cancer ratio, patient's desire for peace of mind, and the need for ongoing monitoring.
Lumpectomy carries a 0.5-1% annual risk of local recurrence in the remaining breast tissue, while mastectomy has up to an 8% lifetime risk of local recurrence.
Some patients may opt for mastectomy specifically to avoid radiation therapy, which is typically administered after a lumpectomy.

Surgeons primarily treat local breast disease, while medical oncologists manage systemic disease, which is crucial for preventing metastasis and ensuring survival.
Systemic treatments include chemotherapy for invasive cancer or estrogen blockers for hormone-positive cancer.
Ductal carcinoma in situ (DCIS) signifies cancer contained within the duct, whereas invasive cancer has breached the duct wall.
DCIS with a lumpectomy typically requires estrogen blockers, but DCIS treated with a bilateral mastectomy does not.

Conventional breast reconstruction often involves multiple surgeries, typically starting with tissue expanders before permanent implants.
Dr. De La Cruz has evolved her practice towards immediate, direct-to-implant breast reconstruction, allowing patients to go home with implants in a single surgery.
This single-stage approach minimizes patient trauma, reduces recovery time, and lowers costs compared to traditional methods.
Nationwide, only 11% of surgeons perform direct-to-implant reconstruction, despite patient satisfaction with the results.

Loss of sensation in the breast and nipple area after mastectomy is a common consequence often not disclosed to patients.
The technique of 'resensation' aims to restore feeling in these areas, but it is not universally offered or covered by insurance.
A 2016 New York Times article highlighted the issue of chest wall numbness post-mastectomy.
Disparities in healthcare are noted, with male orchiectomy patients often receiving immediate reconstruction, while women's breast reconstruction is frequently delayed.

Modern breast cancer surgery emphasizes thoughtful approaches, focusing on improving patients' quality of life during extended survivorship.
Nerve grafting techniques aim to restore sensation to the nipple and surrounding skin after mastectomy, although it is not a perfect science.
The procedure involves identifying and preserving superficial nerves in the chest wall, then connecting them to the nipple area, sometimes using a cadaveric nerve graft.
Full sensation can return within one to two years, significantly improving quality of life by allowing patients to feel touch and temperature, preventing undetected injuries.

Nipple-sparing mastectomies are determined during surgery; if pathology of tissue near the nipple shows clear margins, the nipple is preserved, otherwise it can be removed post-surgery.
Dr. De La Cruz frequently performs single-surgery nipple-sparing mastectomies for patients with larger breasts, combining reduction and lift.
MedStar Georgetown University Hospital utilizes MAGTRACE, an injection that identifies the first lymph node in the lymphatic chain, administered in the operating room.
Since implementing MAGTRACE, 95% of women undergoing mastectomy for DCIS have avoided unnecessary lymph node surgery, preventing complications like lymphedema.